尿核苷检测在结直肠癌诊断与手术治疗监测中的应用

来源 :中华外科杂志 | 被引量 : 0次 | 上传用户:wzgncsyj1
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨尿核苷检测对结直肠癌的诊断价值及在手术治疗监测中的应用。方法采用反相高效液相色谱法检测经结肠镜与活检病理证实的52例结直肠癌患者术前1天与术后第8天尿中14种正常与修饰核苷水平,同时以62例健康人作为对照组,并与传统肿瘤标记物癌胚抗原(CEA),CA199,CA125,甲胎蛋白(AFP)相比较,探讨尿核苷与结直肠癌临床病理特征的关系。结果结直肠癌组14种核苷中假尿嘧啶核苷(Pseu),腺嘌呤核苷(A),胞嘧啶核苷(C),1甲基腺苷(m1A),1甲基次黄嘌呤核苷(m1I),3甲基尿苷+5甲基尿苷(mU),2,2二甲基鸟苷(m22G),次黄嘌呤核苷(I),1甲基鸟苷(m1G),N4乙酰胞苷(ac4C),6甲基腺苷(m6A)等11种核苷水平显著升高,与正常对照组相比差异具有统计学意义(P<0.05);通过主成分分析,76.9%(40/52)的结直肠癌患者被正确识别,敏感性与传统标记物CEA(38.5%),CA199(40.4%),CA125(15.4%),AFP(17.3%)相比差异有统计学意义(均P<0.01);Pseu与m1G的受试者操作特征曲线下面积分别达到0.896与0.816;对8种核苷(Pseu,m1A,m1I,m22G,I,m1G,ac4C,m6A)进行逐步判别分析,发现Pseu、m1G在判别分析中有统计学意义,建立判别函数Y正常人=-3.009+0.0272×Pseu+4.918×m1G,Y结直肠癌=-8.057+0.0667×Pseu+8.258×m1G;40例结直肠癌患者的Pseu,C,U(尿嘧啶核苷) Objective To investigate the diagnostic value of uridine in colorectal cancer and its application in the monitoring of surgical treatment. Methods Fifty-two normal and modified nucleosides in urine of 52 patients with colorectal cancer confirmed by colonoscopy and biopsy were assayed by RP-HPLC at day 1 before operation and on day 8 postoperatively. Sixty-two healthy subjects As control group, and compared with the traditional tumor markers carcinoembryonic antigen (CEA), CA199, CA125, AFP (AFP) to explore the relationship between uridine and colorectal cancer clinicopathological features. Results Among 14 nucleosides of colorectal cancer group, Pseu, A, C, MIA and 1-methylhypoxanthine (M1I), 3 methyluridine + 5 methyluridine (mU), 2,2 dimethyl guanosine (m22G), inosine (I), 1 methylguanosine (m1G) , N4 acetyl-cytidine (ac4C) and 6-methyl adenosine (m6A) were significantly increased compared with the normal control group (P <0.05). By principal component analysis, 76.9 (40/52) of colorectal cancer patients were correctly identified. The sensitivity was statistically different from the traditional markers of CEA (38.5%), CA199 (40.4%), CA125 (15.4%) and AFP (P <0.01). The area under the operating characteristic curve of subjects with Pseu and m1G reached 0.896 and 0.816, respectively. Eight nucleosides (Pseu, m1A, m1I, m22G, I, m1G, ac4C and m6A) Discriminant analysis showed that Pseu and m1G were statistically significant in discriminant analysis. The discriminant function was established as Y = -3.009 + 0.0272 × Pseu + 4.918 × m1G, Y colorectal cancer = -8.057 + 0.0667 × Pseu + 8.258 × m1G; 40 cases of colorectal cancer patients with Pseu, C, U (uridine)
其他文献
目的评价柳州市人群中代谢综合征(MS)的患病情况。方法整群抽取柳州市常住成年居民4092人。进行身高、体质量、腰围、血压、血脂及血糖等指标检测,按中华医学会糖尿病分会提
目的探讨马方综合征合并主动脉根部瘤手术时机、手术方法和疗效总结.方法 1995年2月至2004年10月手术治疗马方综合征主动脉根部瘤84例,其中主动脉夹层41例(Debakey Ⅰ型32例
目的分析额、枕部直接冲击时脑组织的应力响应,探讨颅脑直接冲击导致脑挫裂伤的力学机制.方法利用头颅三维有限元模型,模拟计算8个不同方向额、枕部冲击载荷下脑组织应力应变
目的听性稳态诱发反应(auditory steadystat eresponse,ASSR)新技术与视觉强化测听(visionrein for cementaudiometry,VRA)阈值的相关性分析研究,探讨听神经病症侯群及其鉴别
目的探讨后交通动脉瘤性动眼神经麻痹术后恢复情况,并分析其影响因素.方法回顾分析我院4年来收治的98例后交通动脉瘤患者,其中52例合并有单侧动眼神经麻痹表现,所有患者均经
目的:探讨爱活尿通(Eviprostat)治疗良性前列腺增生(BPH)的安全性及有效性。方法:采用开放、多中心的临床试验方法,对100例BPH患者进行了为期12周的观察。患者服用爱活尿通每
患者,女,40岁,公务员.主因鼻塞、头痛3个月,症状加重伴发热20 d入院.患者4个月前行拔牙术后出现发热3 d,应用消炎药物治疗后好转.1个月后,自感鼻塞、头痛,即在当地医院做CT检
目的探讨延髓显微血管减压术(MVD)治疗原发性高血压的疗效.方法我们选取3例病人,他们都曾经接受过3种以上的抗高血压药物的治疗,血压均没有被很好地控制.术前经头DSA、MRI检
目的研究正常和损伤的膝关节前交叉韧带的MRI表现.方法回顾性分析16例正常前交叉韧带和15例损伤前交叉韧带的MR表现.结果正常前交叉韧带在矢状位上呈一连续笔直的带状影,T1WI
目的:探讨Kras基因在喉鳞状细胞癌细胞株Hep2中的表达及其意义,为喉癌的发生与Kras点突变的相关性研究奠定基础。方法:采用RTPCR技术检测Kras基因mRNA在喉癌细胞株Hep2和胰腺